Search research articles
Contact Us
Filters
Showing results (1-10 of 25) with videos related to
Page
of 3
Sort By:
The New England Journal of Medicine
|
June 28, 2023
Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants. Reply
Ogo Egbuna, Glenn M Chertow
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
May 30, 2007
Rupture of an infected liver cyst into the pericardium in a kidney transplant recipient with polycystic kidney disease
Ogo Egbuna, Scott Johnson, Martha Pavlakis
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
August 28, 2007
Acute crescentic glomerulonephritis in a renal allograft: an unusual complication of fungal infection
Ogo Egbuna, Martha Pavlakis, Isaac E Stillman
Frontiers in Nephrology
|
January 23, 2026
Lower proteinuria is better for patients with IgA nephropathy: a systematic review
Ankit Shah, Manish Maski, Ogo Egbuna, et al.
Glomerular Diseases
|
April 11, 2024
Safety and Tolerability of the APOL1 Inhibitor, Inaxaplin, following Single- and Multiple-Ascending Doses in Healthy Adults
Ogo Egbuna, Vincent Audard, George Manos, et al.
Pharmacology Research & Perspectives
|
December 16, 2014
A clinical therapeutic protein drug-drug interaction study: coadministration of denosumab and midazolam in postmenopausal women with osteoporosis
Graham Jang, Allegra Kaufman, Edward Lee, et al.
Kidney360
|
January 23, 2026
Clinical Characteristics and Disease Progression Among Non-Diabetic APOL1-Mediated Kidney Disease Patients and Patients with Other CKD
Ankit Shah, Manish Maski, Debbie Goldschmidt, et al.
Contemporary Clinical Trials
|
April 19, 2012
The "House Calls" trial: a randomized controlled trial to reduce racial disparities in live donor kidney transplantation: rationale and design
James R Rodrigue, Martha Pavlakis, Ogo Egbuna, et al.
American Journal of Physiology. Renal Physiology
|
May 29, 2009
The full-length calcium-sensing receptor dampens the calcemic response to 1alpha,25(OH)2 vitamin D3 in vivo independently of parathyroid hormone
Ogo Egbuna, Steven Quinn, Lakshmi Kantham, et al.
Transplantation
|
February 8, 2013
Willingness to pursue live-donor kidney transplantation among waitlisted patients infected with human immunodeficiency virus (HIV): a preliminary investigation
James R Rodrigue, Matthew J Paek, Ogo Egbuna, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 25) with videos related to
Sort By:
Page
of 3
The New England Journal of Medicine
|
June 28, 2023
Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants. Reply
Ogo Egbuna, Glenn M Chertow
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
May 30, 2007
Rupture of an infected liver cyst into the pericardium in a kidney transplant recipient with polycystic kidney disease
Ogo Egbuna, Scott Johnson, Martha Pavlakis
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
August 28, 2007
Acute crescentic glomerulonephritis in a renal allograft: an unusual complication of fungal infection
Ogo Egbuna, Martha Pavlakis, Isaac E Stillman
Frontiers in Nephrology
|
January 23, 2026
Lower proteinuria is better for patients with IgA nephropathy: a systematic review
Ankit Shah, Manish Maski, Ogo Egbuna, et al.
Glomerular Diseases
|
April 11, 2024
Safety and Tolerability of the APOL1 Inhibitor, Inaxaplin, following Single- and Multiple-Ascending Doses in Healthy Adults
Ogo Egbuna, Vincent Audard, George Manos, et al.
Pharmacology Research & Perspectives
|
December 16, 2014
A clinical therapeutic protein drug-drug interaction study: coadministration of denosumab and midazolam in postmenopausal women with osteoporosis
Graham Jang, Allegra Kaufman, Edward Lee, et al.
Kidney360
|
January 23, 2026
Clinical Characteristics and Disease Progression Among Non-Diabetic APOL1-Mediated Kidney Disease Patients and Patients with Other CKD
Ankit Shah, Manish Maski, Debbie Goldschmidt, et al.
Contemporary Clinical Trials
|
April 19, 2012
The "House Calls" trial: a randomized controlled trial to reduce racial disparities in live donor kidney transplantation: rationale and design
James R Rodrigue, Martha Pavlakis, Ogo Egbuna, et al.
American Journal of Physiology. Renal Physiology
|
May 29, 2009
The full-length calcium-sensing receptor dampens the calcemic response to 1alpha,25(OH)2 vitamin D3 in vivo independently of parathyroid hormone
Ogo Egbuna, Steven Quinn, Lakshmi Kantham, et al.
Transplantation
|
February 8, 2013
Willingness to pursue live-donor kidney transplantation among waitlisted patients infected with human immunodeficiency virus (HIV): a preliminary investigation
James R Rodrigue, Matthew J Paek, Ogo Egbuna, et al.
Page
of 3